Pfizer stays the course on 2024 outlook after delivering better earnings than Wall Street forecast
Pfizer turned in a better-than-expected fourth quarter, boosted by products outside the drugmaker’s slumping COVID-19 vaccine and treatment.
Read MorePfizer
Pfizer stays the course on 2024 outlook after delivering better earnings than Wall Street forecast
In the fourth quarter, Pfizer said it booked 8% operational revenue growth outside its market-leading COVID vaccine, Comirnaty, and treatment, Paxlovid.
Read More
Pfizer shares plunge after drug giant’s COVID-19 drug sales forecast fall short
Pfizer’s forecast for sales of its COVID-19 vaccine and treatment next year falls more than $5 billion short of the Wall Street consensus. The drugmaker’s sales tumbled in early morning trading.
Read More
Pfizer, which is closing two Triangle facilities, reports $2.4 billion quarterly loss
Pfizer losses were not as great as expected in the third quarter, but a continued decline in sales of its COVID-19 products clipped revenue. Tuesday’s earnings news follows the Oct. 27 decision to close facilities in Durham and Morrisville
Read More
Pfizer shutting down facilities in Durham, Morrisville
Pfizer will close facilities in Durham and Morrisville, part of a company wide “realignment” being made, according to a statement, “to operate more efficiently and effectively.” The company, which includes a COVID-19 vaccine in its vast portfolio, reported a drop in sales through the first half of 2023, but...
Read More
Pfizer resumes ‘majority’ of operations after NC tornado in Rocky Mount
Pfizer announced Monday most operations have resumed at its Rocky Mount plant more than two months after a tornado damaged a main building at the site.
Read More
GSK sues Pfizer in battle over respiratory virus vaccine patents
Drug giants GSK and Pfizer, both with a significant presence in North Carolina, are in a legal battle now over respiratory virus vaccines that received FDA approval in May.
Read More
Pfizer tornado recovery: What was lost in NC tornado, impact on US medicine supply
A powerful EF3 tornado touched down near Rocky Mount on July 19, 2023, damaging a storage warehouse at Pfizer’s pharmaceutical manufacturing facility at 4285 N. Wesleyan Blvd. Two weeks after the tornado, on July 31, Pfizer released a report detailing how much product was damaged and if medical professionals and patients will be impacted. Here are the main findings.
Read More
Pfizer earnings take big hit from tumbling COVID related treatments
Crumbling COVID-19 vaccine and treatment sales chopped Pfizer’s second-quarter earnings, but both the drugmaker and Wall Street expect a rebound in the back half of 2023. Here’s a look at the latest financials and what could be coming next.
Read More
